The complex analysis of risk factors, influencing on the progression of chronic obstructive ulmonary disease

The complex analysis of risk factors, influencing on the progression of chronic obstructive ulmonary disease

Show other versions (1)

Aim. The aim of the study is the analysis of risk factors, influencing on the progression of chronic obstructive pulmonary disease. Materials and methods. 259 patients with chronic obstructive pulmonary disease (COPD) I and III stages, mean age 54,3±11,7 and the duration of the disease 10,1±5,7. P...

Full description

Bibliographic Details
Main Authors:	V.A. NIKITIN, I.A. STARODUBTSEVA, L.V. VASILIEVA, A.V. POPOV
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2018-01-01
Series:	Терапевтический архив
Subjects:	chronic obstructive pulmonary disease risk factors progression markers of systemic inflammation
Online Access:	http://ter-arkhiv.ru/en/archive/2018/vol-90_1_2018/kompleksnyy-analiz-faktorov-riska-vliyayushchikh-na-progressirovanie-khronicheskoy-obstruktivnoy-bol_521/?element

Similar Items

The complex analysis of risk factors, influencing on the progression of chronic obstructive ulmonary disease
by: V A Nikitin, et al.
Published: (2018-01-01)

LASER-ULTRASOUND THERAPY IN THE COMPREHENSIVE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: V. A. Nikitin, et al.
Published: (2018-09-01)

PHYSICAL TRAINING IS A UNIVERSAL METHOD OF PULMONARY REHABILITATION OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: N N Mescheryakova, et al.
Published: (2012-03-01)

ROLE OF SYSTEMATIC INFLAMMATION IN THE DEVELOPMENT OF COMORBIDITY IN CASE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: V. A. Nikitin, et al.
Published: (2017-06-01)

The processes of inflammation and fibrosis in patients with chronic obstructive pulmonary disease
by: T.A. Pertseva, et al.
Published: (2020-12-01)

Chronic obstructive pulmonary disease concurrent with metabolic syndrome: Pathophysiological and clinical features
by: A V Budnevsky, et al.
Published: (2017-01-01)

Activity of systemic inflammatory reaction in patients with chronic obstructive pulmonary disease in regard to small intestinal absorption function
by: E I Beloborodova, et al.
Published: (2009-03-01)

Clinical releveance of hemorrhagic component of endobronchial inflammation in severe chronic obstructive pulmonary disease exacerbation
by: M L Shteiner, et al.
Published: (2019-03-01)

Systemic inflammation in patients with chronic obstructive pulmonary disease and obesity
by: E. S. Ovsyannikov, et al.
Published: (2020-03-01)

Trends in Hospital Admissions for Chronic Obstructive Pulmonary Disease in Men and Women in SPAIN, 1998 to 2018
by: Domingo Orozco-Beltrán, et al.
Published: (2021-04-01)

Issues related to the combination of chronic obstructive pulmonary disease and osteoporosis (review)
by: V. V. Gaynitdinova, et al.
Published: (2019-12-01)

Dependence of cytokinemia on the clinical course of chronic obstructive pulmonary disease combined with hypertension.
by: V.A A. Kapustnyk, et al.
Published: (2018-11-01)

Eosinophils as a non-invasive marker to assess inflammatory activities in those suffering from chronic obstructive pulmonary disease
by: M. A. Kаrnаushkinа, et al.
Published: (2018-11-01)

Arterial stiffness and albuminuria as markers of endothelial dysfunction in those with chronic obstructive pulmonary disease
by: A. A. Bakina, et al.
Published: (2021-04-01)

Comorbidity of chronic heart failure and chronic obstructive pulmonary disease: features of pathogenesis, clinic and diagnostics
by: R. E. Tokmachev, et al.
Published: (2018-12-01)

HISTORIC DEVELOPMENT OF THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE CLASSIFICATION
by: A. V. Nikitin, et al.
Published: (2018-01-01)

A temporal visualization of chronic obstructive pulmonary disease progression using deep learning and unstructured clinical notes
by: Chunlei Tang, et al.
Published: (2019-12-01)

Anemias in chronic obstructive pulmonary disease
by: A V Budnevsky, et al.
Published: (2016-03-01)

CYTOTOXIC LYMPHOCYTES: THE ROLE IN INFLAMMATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATION AND REMISSION
by: N. A. Raspopina, et al.
Published: (2016-02-01)

Assessment of serum interleukin 6 level in patients with chronic obstructive pulmonary disease: is it related to disease severity?
by: Esmat A. Abd Elnaby, et al.
Published: (2020-01-01)

THE CURRENT CHRONIC OBSTRUCTIVE PULMONARY DISEASE SITUATION IN THE REPUBLIC OF SAKHA (YAKUTIA)
by: A. I. Sivtseva, et al.
Published: (2014-03-01)

Clinical Features and the NT-proBNP Marker in Patients with Chronic Heart Failure in the Setting of Atrial Fibrillation and Chronic Obstructive Pulmonary Disease
by: Т. A. Dzyurich, et al.
Published: (2019-09-01)

Study of inflammatory markers and BODE index in chronic obstructive pulmonary disease
by: Priti Lokesh Meshram, et al.
Published: (2018-01-01)

Mean platelet volume as an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease
by: Tamer A. Helmy, et al.
Published: (2016-02-01)

Comparing frequencies of asthma-chronic obstructive pulmonary disease overlap in patients with stable chronic obstructive pulmonary disease
by: Nezar R. Mohamed, et al.
Published: (2019-07-01)

Biomarkers in chronic obstructive pulmonary disease patients for prediction of lung cancer development
by: Murali M S Balla, et al.
Published: (2018-01-01)

Combined antihypertensive therapy in patients with chronic obstructive pulmonary disease
by: M. V. Matsievich, et al.
Published: (2008-08-01)

METHOD FOR THE PREDICTION OF THE DEVELOPMENT OF CHRONIC PULMONARY HEART IN COAL WORKERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: O. Yu. Korotenko, et al.
Published: (2013-05-01)

COMBINATION THERAPY WITH BISOPROLOL AND AMLODIPINE IN TREATMENT OF ARTERIAL HYPERTENSION PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: V. A. Nikitin, et al.
Published: (2015-08-01)

Review of the association between periodontitis and chronic obstructive pulmonary disease in smokers
by: Agathi Spiropoulou, et al.
Published: (2019-03-01)

Risk of Chronic Obstructive Pulmonary Disease Exacerbation in Patients Who Use Methotrexate—A Nationwide Study of 58,580 Outpatients
by: Christina Marisa Bergsøe, et al.
Published: (2021-05-01)

Elastic properties of pulmonary artery in chronic obstructive pulmonary disease
by: S. Ya. Dotsenko, et al.
Published: (2017-02-01)

CHRONIC OBSTRUCTIVE LUNG DISEASE AS RISK FACTOR FOR CARDIOVASCULAR DISORDERS
by: A. V. Budnevsky, et al.
Published: (2016-06-01)

CLINICAL AND IMMUNOLOGICAL CORRELATIONS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND BRONCHIAL ASTHMA
by: E. G. Shuganov, et al.
Published: (2016-02-01)

Association between blood pressure, inflammation and spirometry parameters in chronic obstructive pulmonary disease
by: Sulhattin Arslan, et al.
Published: (2019-01-01)

Role of neutrophil to lymphocyte ratio in prediction of acute exacerbation of chronic obstructive pulmonary disease
by: Aida M. Yousef, et al.
Published: (2017-01-01)

ROLE OF IL-4, IL-6, IL-8, IL-10 CYTOKINES IN THE IMMUNOPATHOGENESIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: E. Yu. Trushina, et al.
Published: (2019-01-01)

IMMUNE AND METABOLIC PHENOTYPES OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN MEN
by: E. P. Kalinina, et al.
Published: (2014-08-01)

Extra pulmonary boosting in chronic obstructive pulmonary disease: leverage of piracetam as an adjunctive therapy on respiratory and neuropsychiatric functions in patients with chronic obstructive pulmonary disease
by: Ahmed M Abumossalam, et al.
Published: (2021-01-01)

Functional and radiological characteristics of asthma combined chronic obstructive pulmonary disease overlap
by: Hamada K. Fayed, et al.
Published: (2020-01-01)